Skip to main content
Premium Trial:

Request an Annual Quote

Spotfire Closes $6M Round; Chambon Will Join Board

Premium

CAMBRIDGE, Mass.--Swedish software maker Spotfire, which has a US headquarters here, last week closed its second round of venture capital financing, having raised $6 million. The round was lead by the Sprout Group, whose general partner, Philippe Chambon, will join the Spotfire board of directors. Current investors Atlas Ventures and InnovationsKapital also participated in the round.

Rock Gnatovich, Spotfire's president, said the financing will support the company's continued expansion into the pharmaceutical market, where it has already secured 22 customers, and its entry into other industries.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.